Virtus LifeSci Biotech Products ETF
21 hedge funds and large institutions have $15.1M invested in Virtus LifeSci Biotech Products ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $16.2M → $15.1M (-$1.17M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$772K | |
| 2 | +$231K | |
| 3 | +$213K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$83K |
| 5 |
SMG
Smart Money Group
Eastland,
Texas
|
+$58.8K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$148K | |
| 3 | -$51.8K | |
| 4 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$41K |
| 5 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
-$9K |